| Authors: |
Hambach B; Laboratory of Hearing Biology and Therapeutics, National Institute on Deafness and Other Communication Disorders (NIDCD), NIH, Bethesda, MD, USA.; Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA., Bilokon A; Auditory and Vestibular Clinical Research Section (AVCRS), National Institute on Deafness and Other Communication Disorders (NIDCD), NIH, Bethesda, MD, USA., Lee J; Laboratory of Hearing Biology and Therapeutics, National Institute on Deafness and Other Communication Disorders (NIDCD), NIH, Bethesda, MD, USA., Allemang LN; Auditory and Vestibular Clinical Research Section (AVCRS), National Institute on Deafness and Other Communication Disorders (NIDCD), NIH, Bethesda, MD, USA., Chisholm J; Auditory and Vestibular Clinical Research Section (AVCRS), National Institute on Deafness and Other Communication Disorders (NIDCD), NIH, Bethesda, MD, USA., Zalewski CK; Auditory and Vestibular Clinical Research Section (AVCRS), National Institute on Deafness and Other Communication Disorders (NIDCD), NIH, Bethesda, MD, USA., Christensen J; Auditory and Vestibular Clinical Research Section (AVCRS), National Institute on Deafness and Other Communication Disorders (NIDCD), NIH, Bethesda, MD, USA., Brewer CC; Auditory and Vestibular Clinical Research Section (AVCRS), National Institute on Deafness and Other Communication Disorders (NIDCD), NIH, Bethesda, MD, USA., Gulley JL; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute (NCI), NIH, Bethesda, MD, USA., Allen CT; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute (NCI), NIH, Bethesda, MD, USA., Cunningham LL; Laboratory of Hearing Biology and Therapeutics, National Institute on Deafness and Other Communication Disorders (NIDCD), NIH, Bethesda, MD, USA., Fernandez KA; Laboratory of Hearing Biology and Therapeutics, National Institute on Deafness and Other Communication Disorders (NIDCD), NIH, Bethesda, MD, USA. Katharine.Fernandez@nih.gov. |
